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Study design: Randomized controlled trial of physical exercise and dopaminergic agonist in
persons with spinal cord injury and periodic leg movement (PLM).
Objective: The objective of the present study was to compare the eﬀectiveness of physical
exercise and of a dopaminergic agonist in reducing the frequency of PLM.
Setting: Centro de Estudos em Psicobiologia e Exercı´cio. Universidade Federal de Sa˜o Paulo,
Brazil.
Methods: A total of 13 volunteers (mean age: 31.678.3 years) received L-DOPA (200mg) and
benserazide (50mg) 1 h before sleeping time for 30 days and were then submitted to a physical
exercise program on a manual bicycle ergometer for 45 days (3 times a week).
Results: Both L-DOPA administration (35.11–19.87 PLM/h, Po0.03) and physical exercise
(35.11–18.53 PLM/h, Po0.012) signiﬁcantly reduced PLM; however, no signiﬁcant diﬀerence
was observed between the two types of treatment.
Conclusions: The two types of treatment were found to be eﬀective in the reduction of PLM;
however, physical exercise is indicated as the ﬁrst treatment approach, while dopaminergic
agonists or other drugs should only be recommended for patients who do not respond to this
type of treatment.
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Introduction
Restless legs syndrome (RLS) and periodic limb
movement (PLM) were originally described in 1945
and 1960.1,2 PLM is an asleep phenomenon, characterized
by periodic episodes of repetitive and highly stereotyped
limb movements. These disturbances may result in
decreased sleep eﬃciency and sleep quality.
A growing number of studies on the treatment of RLS
and PLM using increasingly sophisticated methodolo-
gies and designs have been published. Clinical features,
diagnostic standards, epidemiology, and some aspects of
the pathophysiology of RLS and PLM have been
studied and further clariﬁed.3,4
Recently, a high incidence of PLM and RLS has been
reported in subjects with spinal cord lesions.5–8 These
subjects spontaneously report sleep problems, and even
mention the need to be tied to the bed so as to avoid
falling on the ﬂoor due to the frequency of lower limb
movements during sleep.7
Polysomnography, especially all-night studies, sup-
ports the diagnosis of RLS by documenting the sleep
disturbances and PLM by recording the K-complex. The
K-complex is the characteristic wave stage II sleep and
occurs with the leg jerk in PLM, roughly assuming the
time course of cyclic, alternating patterns.9–11 The
relationship between RLS and the occurrences of K-
complexes and a-activity has been described.12 There is
also an important positive correlation between PLM
and K-complexes in spinal cord injured and nonpar-
aplegic subjects.8 All-night polysomnographic ﬁndings
have shown that an increasing sleep latency, an
increased number of arousals and decreasing sleep
eﬃciency were all associated with the worsening of
symptoms.13,14
The treatment for these disorders can be divided
into several categories: (1) primary treatment to
reduce subjective symptoms, (2) speciﬁc treatment
directed at an underlying cause, (3) eﬃcacy and
usefulness of secondary treatment, and (4) ancillary
treatments of a nonpharmacological nature that may
assist therapy.15
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Speciﬁc treatment includes medication selected from
the three primary classes whose eﬀectiveness in RLS/
PLM has been well established: dopaminergic agents,
opioids, and benzodiazepines. Several studies have
reported a favorable treatment outcome of PLM with
dopaminergic agonists.16,17 Dopaminergic agents are
useful for the treatment of both RLS and PLM,
improving all cardinal features of RLS/PLM including
subjective discomfort, dyskinesias while awake, and
sleep quality. Dopamine precursors were ﬁrst used and
included either regular carbidopa/L-DOPA or sus-
tained–release compounds. Typical doses were 25/100–
100/400 (carbidopa/L-DOPA) taken in divided doses
before bedtime or before bedtime and during the night.
Reduction of the incidence of PLM and RLS
following acute physical activity in these patients may
be helpful for the identiﬁcation of the mechanisms
underlying PLM and RLS.7 Thus, it is possible that the
reduction of limb movements may stem from endorphin
secretion induced by the physical activity,18 since the
treatment with opiates often results in a reduction of
PLM.19
The objective of the present study was to compare
the eﬀects of a dopamine agonist and physical exercise
on the treatment of PLM in the spinal cord injury
subjects.
Methodology
After all experimental procedures were approved by the
Ethics Committee Federal University of Sa˜o Paulo, 13
male volunteers (mean age: 31.678.3 years) were
selected following contact through associations for the
disabled in the State of Sa˜o Paulo, Brazil. The selected
individuals were clinically stable, with no complications,
had a spinal cord injury between T7 and T12 and
impairment A¼ complete (following ASIA scales).20
(Table 1) Total injury to the upper motoneurons as
conﬁrmed by radiologic, tomographic, neuroimaging
analysis and that they presented index of PLM above
5 PLM/h, diagnosed by means of polysomnography
accomplished previously.
A cross-sectional study was conducted in which all
volunteers were submitted to the administration of L-
DOPA and physical training. L-DOPA (200mg) in
combination with benserazide chloride (50mg), or
placebo was administered for 30 days, 1 h prior to
sleeping time. This period of drug administration was
followed by a 15-day washout period.
Training was prescribed after all the spinal cord
injured individuals underwent a cardiopulmonary ex-
ercise test on a computerized metabolic gas exchange
system (Vista Turbo Fit, Vacumed, Ventura, CA, USA)
using a calibrated electromagnetically braked arm-crank
ergometer (CYBEX MET-300, Cybex, USA). The
protocol of the maximum eﬀort test consisted of a
2-min warm-up with a load of 25W in 5-W/min load
increments until exhaustion, with 3min of active
recovery at a load of 25W. Mean rotation speed was
70–80 rpm. The data were calculated automatically
using the standard formulae and displayed in a
descriptive numerical and graphic form (average of
20 s). The following data were obtained: oxygen uptake
(ml/min STPD), carbon dioxide production (VCO2, ml/
min STPD), respiratory exchange ratio, minute ventila-
tion (VE, l/min BTPS), respiratory frequency (breaths
per min); ventilatory equivalent for O2 and CO2 (VE/
VO2 and VE/VCO2); expired fraction of O2 and CO2
(FEO2 and FECO2, mmHg); heart rate (HR, bpm), and
oxygen pulse (VO2/HR, ml/bpm). VO2 at the anaerobic
threshold (VO2AT) was estimated by the ventilatory
method, when VE/VO2 and FEO2 increased while VE/
VCO2 and FECO2 remained stable. In the present study,
VO2AT was identiﬁed in all the patients studied.
The anaerobic ventilatory threshold is a convenient
mark used to delimit the upper intensity of aerobic
exercise in training programs, corresponding to the
work intensity at which the respiratory response to
gradual exercise ﬁrst deviates from linearity - LV1.
The training sessions were held on 45 consecutive
days, three times a week, with a mean duration of
30min, according to the results obtained during the
maximum eﬀort test. Total training time depended on
the parameters evaluated (heart rate and W). During the
sessions, heart rate was monitored and kept at the values
established for LV1. Blood pressure measurements were
made before and after each training session.
Polysomnography (PSG-Oxford/Medilog eight chan-
nels) was performed at the Sleep Institute of the Federal
University of Sa˜o Paulo (UNIFESP/EPM) and the
variables observed were three electroencephalogram
channels, two electro-oculogram channels, and three
electromyogram channels, one of them submandibular
and two on the legs (electromyographic recordings of
the lower legs were obtained from the tibial muscle
and femoris of the thigh). Polysomnographic data
were obtained before and after intervention (physical
exercise and L-DOPA). Data on leg movements (PLM)
were analyzed by the Wilcoxon matched paired test,
with the level of signiﬁcance set at Po0.05.
Table 1 Identiﬁcation of the patients containing neurological
level, time injury (months), age, weight (kg) and stature (cm)
Patients
Neurological
level
Time injury
(months)
Age
(years)
Weight
(kg)
Stature
(cm)
1 T9 49 27 44,00 168
2 T9 109 27 53,70 168
3 T11 132 22 68,00 162
4 T11 192 33 72,70 180
5 T12 161 28 67,40 170
6 T12 165 48 62,20 165
7 T11 231 41 42,80 175
8 T9 90 33 63,00 180
9 T10 152 35 72,40 169
10 T11 55 22 53,00 172
11 T10 94 35 65,60 167
12 T11 39 35 61,80 173
13 T7 10 24 57,00 165
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Results
Physical exercise led to a signiﬁcant reduction in the
frequency of PLM, as seen when comparing basal
polysomnographic data with those obtained after 45
days of training (Po0.02). A signiﬁcant reduction in the
frequency of PLM was also observed with the admin-
istration of L-DOPA (Po0.03) (Table 2).
Discussion
The two types of treatment were eﬀective in reducing
PLM. The reduction of PLM in paraplegic subjects
upon physical exercise might be due to the release of b-
endorphin and dopamine during exercise. Thus, physical
exercise should be prescribed as a treatment approach to
PLM and RLS, also in view of its beneﬁcial eﬀects on
the quality of life and sleep.21–23
The initial hypothesis involving physical exercise is
that the reduction of PLM might be inﬂuenced by an
increase in the release of b-endorphin and dopamine
during and after physical exercise, leading to an increase
in the activity of the opiate and dopaminergic system,24
thus decreasing PLM scores.
Bulbulian and Darados25 reported an action of -
endorphins on muscle relaxation in the brain and spinal
cord, with correlations between exercise intensity and
volume and b-endorphin release/action being demon-
strable. Ferreira et al26–28 observed pain mediation by
opiate receptors at the peripheral level. Since opiate
agonists have been shown to be eﬀective in the treatment
of PLM, -endorphin release during and after physical
exercise might have been mediated by opiate receptors at
both the central24 and peripheral level26–28 in the
volunteers studied here.
With respect to dopaminergic agonists, one hypoth-
esis accounting for this imbalance may involve the
maintenance of a monosynaptic pathway capable of
regulating the transmission of dopaminergic stimuli.
Dopamine, by stimulating dopaminergic D2 receptors,
might inhibit central cholinergic transmission yielding a
neurochemical balance (excitatory/inhibitory), which
would prevent the occurrence of such abnormal move-
ments. In our group of paraplegic subjects with complete
spinal cord injury, this monosynaptic pathway might
have been compromised, leading to the occurrence of
such abnormal movements (PLM). Exogenous L-
DOPA, seemingly, would reinstate this balance, redu-
cing abnormal movements of the lower limbs.29
The results demonstrate that the two types of
intervention were eﬃcient in reducing PLM in para-
plegic individuals. A signiﬁcant reduction in the
frequency of PLM was observed for the two treatments
when compared to basal levels, but there was no
signiﬁcant diﬀerence between treatments. Dopaminergic
agonists are only recommended for patients who do not
respond to physical exercise.
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